DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,515,000 | +21.1% | 39,542 | -0.6% | 2.87% | +6.3% |
| Q2 2020 | $7,034,000 | +27.1% | 39,779 | -0.6% | 2.70% | +1.7% |
| Q1 2020 | $5,536,000 | -13.4% | 40,000 | -4.0% | 2.65% | +12.2% |
| Q4 2019 | $6,392,000 | +2.9% | 41,645 | -3.1% | 2.37% | -2.4% |
| Q3 2019 | $6,210,000 | +1.5% | 42,995 | +0.4% | 2.42% | +0.7% |
| Q2 2019 | $6,120,000 | +10.3% | 42,820 | +1.9% | 2.40% | -2.8% |
| Q1 2019 | $5,549,000 | +32.4% | 42,030 | +3.4% | 2.48% | +9.4% |
| Q4 2018 | $4,191,000 | -3.2% | 40,643 | +2.0% | 2.26% | +5.5% |
| Q3 2018 | $4,330,000 | +9.6% | 39,846 | -0.4% | 2.14% | +8.1% |
| Q2 2018 | $3,949,000 | -0.2% | 40,021 | -0.9% | 1.98% | -3.9% |
| Q1 2018 | $3,955,000 | +8.6% | 40,396 | +2.9% | 2.06% | +6.7% |
| Q4 2017 | $3,643,000 | +7.8% | 39,246 | -0.4% | 1.94% | +4.5% |
| Q3 2017 | $3,379,000 | +6.6% | 39,396 | +4.9% | 1.85% | +7.3% |
| Q2 2017 | $3,169,000 | +5.4% | 37,546 | +6.8% | 1.72% | +3.0% |
| Q1 2017 | $3,006,000 | +20.7% | 35,146 | +9.8% | 1.67% | +6.2% |
| Q4 2016 | $2,491,000 | +1.9% | 31,996 | +2.6% | 1.58% | +0.1% |
| Q3 2016 | $2,444,000 | -16.3% | 31,174 | +7.8% | 1.58% | -16.3% |
| Q2 2016 | $2,921,000 | +11.3% | 28,925 | +4.5% | 1.88% | +8.4% |
| Q1 2016 | $2,625,000 | +5.2% | 27,675 | +3.0% | 1.74% | +8.2% |
| Q4 2015 | $2,496,000 | +35.4% | 26,875 | +24.1% | 1.60% | +23.0% |
| Q3 2015 | $1,844,000 | 0.0% | 21,650 | +0.5% | 1.30% | +4.1% |
| Q2 2015 | $1,844,000 | +7.3% | 21,550 | +6.4% | 1.25% | -14.2% |
| Q1 2015 | $1,719,000 | +80.4% | 20,250 | +82.2% | 1.46% | +95.1% |
| Q4 2014 | $953,000 | +31666.7% | 11,115 | +27687.5% | 0.75% | +37350.0% |
| Q1 2014 | $3,000 | 0.0% | 40 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $3,000 | – | 40 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |